Parliamentary Search

Written statement made by Baroness Hodge of Barking (Labour) on Thursday, 17 November 2005 in the House of Commons, on behalf of the Department for Work and Pensions.

Vinyl Chloride Monomer-Related Diseases

The Industrial Injuries Advisory Council report has today been laid before Parliament. After careful consideration, I have accepted the recommendations. Amending legislation will be laid before Parliament. In brief the changes are as follows: In the case of Prescribed Disease C24 prescription has been changed from:

Prescribed Disease Occupation
C24 (a) Angiosarcoma of the liver; (b) acro-osteolysis characterised by: (i) lytic destruction of the terminal phalanges, (ii) in Raynaud's phenomenon, the exaggerated vasomotor response to cold causing intense blanching of the digits, and (iii) sclerodermatous thickening of the skin; (c) liver fibrosis Exposure to Vinyl Chloride Monomer in the manufacture of polyvinyl chloride

to:

Prescribed disease Occcupation
C24Exposure to Vinyl Chloride Monomer causing: (a) Angiosarcoma of the liver; or (b) Osteolysis of the terminal phalanges of the fingers; or (c) Vinyl-chloride monomer-related Raynaud's phenomenon; or (d) Vinyl-chloride monomer-related sclerodermatous thickening of the skin, particularly but not exclusively of the hands; or (e) Liver fibrosis. Work involving exposure to Vinyl Chloride Monomer in the manufacture of polyvinyl chloride. (C24c occurs in the absence of C24a, b, d, or e the occupational exposure must have occurred before 1 January 1984). [Exposure to polyvinyl chloride (PVC) is not a cause of the prescribed disease].

Copies of the report have been placed in the Library, and are available to hon. Members from the Vote Office.

Secondary information

Type
Written statement
Reference
439 c86WS 
Session
2005-06
Related items
Subjects
Industrial diseases Vinyl chloride
Link
View this Written statement on www.publications.parliament.uk